Schedule 13G ownership disclosure
Arbutus Biopharma Corp
Common Shares, without par value · CUSIP: 03879J100
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Two Seas Capital LP
Shares: 10,443,317 · Class: 5.4%
- Two Seas Capital GP LLC
Shares: 10,443,317 · Class: 5.4%
- Sina Toussi
Shares: 10,443,317 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001315863-25-000605
- Form type
- SCHEDULE 13G
- Filer
- Arbutus Biopharma Corp
- CIK
- CIK 1447028
- Filed
- Aug 13, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership